Dimensions of executive function in Parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 20, Issue 2-3, 2005, Pages 140-144

  Weintraub, Daniel ^a,b,d   Moberg, Paul J ^a,b   Culbertson, William C ^c   Duda, John E ^a,b   Katz, Ira R ^b   Stern, Matthew B ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Inhibitory control; Parkinson disease, executive impairment; Planning function

Indexed keywords

ADULT; AGED; APATHY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATION; FEMALE; FUNCTION TEST; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; MOTIVATION; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; COGNITION; DEPRESSION; EDUCATION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE;

EID: 23944449320     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087043     Document Type: Article

References (36)

1. Aarsland D, Tandberg E, Larsen JP, et al: Frequency of dementia in Parkinson's disease. Arch Neurol 1996;53:538-542.
2. Aarsland D, Andersen K, Larsen JP, et al: Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
3. Giladi N, Treves TA, Paleacu D, et al: Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000;107:59-71.
4. Levy G, Tang M-X, Louis ED, et al: The association of incident dementia with mortality in PD. Neurology 2002;59:1708-1713.
5. Levin BE, Katzen HL: Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease; in Weiner WJ, Lang AE (eds): Behavioral Neurology of Movement Disorders. Adv Neurol. New York, Raven, 1995, vol 65, pp 85-95.
6. Green J, McDonald WM, Vitek JL, et al: Cognitive impairments in advanced PD without dementia. Neurology 2002;59:1320-1324.
7. Fuster JM: Frontal lobe syndromes; in Fogel BS, Schiffer RB, Rao SM (eds): Neuropsychiatry. Baltimore, Williams & Wilkins, 1996, pp 407-413.
8. Dubois B, Pillon B: Cognitive deficits in Parkinson's disease. J Neurol 1997;244:2-8.
9. MacDonald AW, Coehn JD, Stenger VA, et al: Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000;288:1835-1838.
10. Wertman E, Speedie L, Shemesh Z, et al: Cognitive disturbances in Parkinsonian patients with depression. J Neuropsychiatry Neuropsychol Behav Neurol 1993;6:31-37.
11. Kuzis G, Sabe L, Tiberti C, Leiguarda R, Starkstein SE: Cognitive functions in major depression and Parkinson disease. Arch Neurol 1997;54:982-986.
12. Tröster AI, Stalp LD, Paolo AM, Fields JA, Koller WC: Neuropsychological impairment in Parkinson's Disease with and without depression. Arch Neurol 1995;52:1164-1169.
13. Isella V, Melzi P, Grimaldi M, et al: Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord 2002;17:366-371.
14. Pluck GC, Brown RG: Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002;73:636-642.
15. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG: Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992;4:134-139.
16. Folstein MF, Holstein SE, McHugh PR: 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:196-198.
17. Crum RM, Anthony JC, Bassett SS, et al: Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 1993;269:2386-2391.
18. DX) Technical Manual. North Tonawanda, Multi-Health Systems, 2001.
19. Reitan R: Validity of the Trail-Making Test as an indicator of organic brain disease. Percept Psychomot Skills 1958;8:271-276.
20. Stroop JR: Studies of inference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
21. Golden C: The Stroop Color and Word Test. Wood Dale, Stoelting Company, 1994.
22. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
23. Sheikh JI, Yesavage JA: Geriatric Depression Scale (GDS): recent evidence and development of a shorter version; in Brink TL (ed): Clinical Gerontology: A Guide to Assessment and Intervention. New York, Haworth Press, 1986, pp 165-173.
24. Johns MW: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
25. Fahn S, Elton RL, Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale; Fahn S, Marsden CD, Calne DB, Lieberman A (eds): Recent Developments in Parkinson's Disease. Florham Park, Macmillan Health Care Information, 1987, pp 153-163.
26. Hoehn MH, Yahr MD: Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
27. SPSS for Windows, version 12.0. Chicago, SPSS Inc., 2003.
28. Dujardin K, Degreef JF, Rogelet P, et al: Impairment of the supervisory attentional system in early untreated patients with Parkinson's disease. J Neurol 1999;246:783-788.
29. Dagher A, Owen AM, Boecker H, et al: Mapping the network for planning: a correlational PET activation study with the Tower of London task. Brain 1999;122:1973-1987.
30. Royall DR, Lauterbach EC, Cummings JL, et al: Executive control function: a review of its promise and challenges for clinical research. J Neuropsychiatry Clin Neurosci 2002;14:377-405.
31. 18F]fluoro-L- dopa PET study. Brain 2002;125:1358-1365.
32. Ouchi Y, Yoshikawa E, Okada H, et al: Alterations in bindingsite density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-cFT binding with positron emission tomography. Ann Neurol 1999;45:601-610.
33. Owen AM: Cognitive planning in humans: neuropsychological, neuroanatomical and neuropharmacological perspectives. Prog Neurobiol 1997;53:431-450.
34. Bruck A, Portin R, Lindell A, et al: Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 2001;311:81-84.
35. Schroeder U, Kuehler A, Haslinger B, et al: Subthalamic nucleus stimulation affects striato-anterior cingulate cortex circuit in a response conflict task: a PET study. Brain 2002;125:1995-2004.
36. Rogers D, Lees AJ, Smith E, et al: Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness. Neuropsychologia 2003;41:645-654.